白血糖指数及其在糖尿病和非糖尿病急性肺栓塞患者的预后影响
Nuray Aslan1, Fatih Güneysu2, Yusuf Yürümez2
1Department of Emergency Medicine, Sakarya University Education and Research Hospital, Adapazarı, Turkey.
概括
白血糖指数 (LGI) 不能预测急性肺栓塞 (APE) 患者的死亡率,无论糖尿病状况如何. 在糖尿病APE患者中观察到较高的死亡率,但LGI不是显著的预后因素.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 肺部病理学 肺部病理学
背景情况:
- 白血糖指数 (LGI) 结合了白细胞计数和血糖水平.
- 急性肺栓塞 (APE) 是致病率和死亡率的重要原因.
- 糖尿病是一种已知的心血管事件的风险因素,可能会影响APE结果.
研究的目的:
- 评估LGI在APE患者的预后价值.
- 为了比较LGI对APE患者糖尿病和没有糖尿病患者的死亡率的预测能力.
主要方法:
- 对199名被诊断患有APE的患者进行了回顾性研究.
- 患者被分为糖尿病和非糖尿病组.
- 基于LGI截止值的30天内所有原因死亡率的分析.
主要成果:
- 糖尿病APE患者组的死亡率更高.
- 简化的肺栓塞严重性指数得分≥1独立预测了非糖尿病患者的死亡率.
- 没有发现LGI是糖尿病或非糖尿病APE患者30天全因死亡率的独立预测因子.
结论:
- 糖尿病与APE患者的死亡率增加有关.
- LGI似乎不是APE患者死亡率的可靠独立预测指标.
- 需要进一步的研究来验证这些发现,因为目前对LGI在APE的研究有限.
相关概念视频
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Acute Pancreatitis II: Clinical Manifestations and Management
84
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
84
Radiological Investigation III: Pulmonary Angiogram and PET Scan
82
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
82
Diabetes: Symptoms, Diagnosis, and Complications
499
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
499
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
146
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
146
Oral Hypoglycemic Agents: Glinides
133
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
133


